145 related articles for article (PubMed ID: 20947846)
1. Anamnestic recall of stroke-related deficits: an animal model.
Zierath D; Hadwin J; Savos A; Carter KT; Kunze A; Becker KJ
Stroke; 2010 Nov; 41(11):2653-60. PubMed ID: 20947846
[TBL] [Abstract][Full Text] [Related]
2. Induction of immunologic tolerance to myelin basic protein prevents central nervous system autoimmunity and improves outcome after stroke.
Gee JM; Kalil A; Thullbery M; Becker KJ
Stroke; 2008 May; 39(5):1575-82. PubMed ID: 18323496
[TBL] [Abstract][Full Text] [Related]
3. Sensitization to brain antigens after stroke is augmented by lipopolysaccharide.
Becker KJ; Kindrick DL; Lester MP; Shea C; Ye ZC
J Cereb Blood Flow Metab; 2005 Dec; 25(12):1634-44. PubMed ID: 15931160
[TBL] [Abstract][Full Text] [Related]
4. Chemical Sympathectomy, but not Adrenergic Blockade, Improves Stroke Outcome.
Zierath D; Olmstead T; Stults A; Shen A; Kunze A; Becker KJ
J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):3177-3186. PubMed ID: 30120036
[TBL] [Abstract][Full Text] [Related]
5. Adoptive transfer of myelin basic protein-tolerized splenocytes to naive animals reduces infarct size: a role for lymphocytes in ischemic brain injury?
Becker K; Kindrick D; McCarron R; Hallenbeck J; Winn R
Stroke; 2003 Jul; 34(7):1809-15. PubMed ID: 12791945
[TBL] [Abstract][Full Text] [Related]
6. CNS immune responses following experimental stroke.
Zierath D; Thullbery M; Hadwin J; Gee JM; Savos A; Kalil A; Becker KJ
Neurocrit Care; 2010 Apr; 12(2):274-84. PubMed ID: 19714497
[TBL] [Abstract][Full Text] [Related]
7. The contribution of antibiotics, pneumonia and the immune response to stroke outcome.
Becker KJ; Zierath D; Kunze A; Fecteau L; Lee B; Skerrett S
J Neuroimmunol; 2016 Jun; 295-296():68-74. PubMed ID: 27235351
[TBL] [Abstract][Full Text] [Related]
8. Promiscuity of autoimmune responses to MBP after stroke.
Zierath D; Kunze A; Fecteau L; Becker K
J Neuroimmunol; 2015 Aug; 285():101-5. PubMed ID: 26198925
[TBL] [Abstract][Full Text] [Related]
9. Immunologic tolerance to myelin basic protein decreases stroke size after transient focal cerebral ischemia.
Becker KJ; McCarron RM; Ruetzler C; Laban O; Sternberg E; Flanders KC; Hallenbeck JM
Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10873-8. PubMed ID: 9380727
[TBL] [Abstract][Full Text] [Related]
10. Amplification of regulatory T cells using a CD28 superagonist reduces brain damage after ischemic stroke in mice.
Na SY; Mracsko E; Liesz A; Hünig T; Veltkamp R
Stroke; 2015 Jan; 46(1):212-20. PubMed ID: 25378432
[TBL] [Abstract][Full Text] [Related]
11. Atorvastatin Modulates Regulatory T Cells and Attenuates Cerebral Damage in a Model of Transient Middle Cerebral Artery Occlusion in Rats.
Rodríguez-Perea AL; Gutierrez-Vargas J; Cardona-Gómez GP; Guarin CJ; Rojas M; Hernández PA
J Neuroimmune Pharmacol; 2017 Mar; 12(1):152-162. PubMed ID: 27614888
[TBL] [Abstract][Full Text] [Related]
12. Brain Ischemia Induces Diversified Neuroantigen-Specific T-Cell Responses That Exacerbate Brain Injury.
Jin WN; Gonzales R; Feng Y; Wood K; Chai Z; Dong JF; La Cava A; Shi FD; Liu Q
Stroke; 2018 Jun; 49(6):1471-1478. PubMed ID: 29695462
[TBL] [Abstract][Full Text] [Related]
13. Splenic responses play an important role in remote ischemic preconditioning-mediated neuroprotection against stroke.
Chen C; Jiang W; Liu Z; Li F; Yang J; Zhao Y; Ran Y; Meng Y; Ji X; Geng X; Du H; Hu X
J Neuroinflammation; 2018 May; 15(1):167. PubMed ID: 29807548
[TBL] [Abstract][Full Text] [Related]
14. Splenectomy Does Not Improve Long-Term Outcome After Stroke.
Zierath D; Shen A; Stults A; Olmstead T; Becker KJ
Stroke; 2017 Feb; 48(2):497-500. PubMed ID: 28087806
[TBL] [Abstract][Full Text] [Related]
15. Prereperfusion saline infusion into ischemic territory reduces inflammatory injury after transient middle cerebral artery occlusion in rats.
Ding Y; Li J; Rafols JA; Phillis JW; Diaz FG
Stroke; 2002 Oct; 33(10):2492-8. PubMed ID: 12364743
[TBL] [Abstract][Full Text] [Related]
16. Delayed-type hypersensitivity response in experimental autoimmune neuritis treated with peptide-coupled spleen cells.
Gregorian SK; Rostami A
J Neuroimmunol; 1994 Apr; 51(1):69-75. PubMed ID: 7512578
[TBL] [Abstract][Full Text] [Related]
17. Antibody to the alpha4 integrin decreases infarct size in transient focal cerebral ischemia in rats.
Becker K; Kindrick D; Relton J; Harlan J; Winn R
Stroke; 2001 Jan; 32(1):206-11. PubMed ID: 11136938
[TBL] [Abstract][Full Text] [Related]
18. White matter injury and microglia/macrophage polarization are strongly linked with age-related long-term deficits in neurological function after stroke.
Suenaga J; Hu X; Pu H; Shi Y; Hassan SH; Xu M; Leak RK; Stetler RA; Gao Y; Chen J
Exp Neurol; 2015 Oct; 272():109-19. PubMed ID: 25836044
[TBL] [Abstract][Full Text] [Related]
19. α-MSH: a potential neuroprotective and immunomodulatory agent for the treatment of stroke.
Savos AV; Gee JM; Zierath D; Becker KJ
J Cereb Blood Flow Metab; 2011 Feb; 31(2):606-13. PubMed ID: 20700130
[TBL] [Abstract][Full Text] [Related]
20. PD-L1 Monoclonal Antibody Treats Ischemic Stroke by Controlling Central Nervous System Inflammation.
Bodhankar S; Chen Y; Lapato A; Dotson AL; Wang J; Vandenbark AA; Saugstad JA; Offner H
Stroke; 2015 Oct; 46(10):2926-34. PubMed ID: 26306753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
